Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

Within minutes of the United States hiking tariffs on all Chinese imports by 10 per cent, Beijing announced a slew of retaliatory measures in a bid to gain leverage in any future trade negotiations ...

“The U.S.’s unilateral tariff increase seriously violates the rules of the World Trade Organization,” China’s ... which owns ...

With technology advancements dramatically improving the cost, accuracy, and time to map a person’s ... 25,000 sequencing systems, Illumina holds around 80% of the global market.

Market OverviewThe Global Carrier Screening Market is a genetic testing process that determines whether an individual carries ...

China has launched an antitrust investigation into Google alongside retaliatory tariffs after the US imposed 10 per cent tariffs on products from the country. The State Administration for Market ...

Precision medicine is an innovative approach in healthcare that takes into account individual differences in genes, ...

The recent announcement from the Chinese Ministry of Commerce poses potential risks, as China represents approximately 7% of Illumina Inc (NASDAQ:ILMN)'s global revenue. Sequencing instruments ...

Carl Icahn’s Icahn Capital disclosed in an SEC filing its holdings as of December 31, 2024. The fund increased its stakes in two holdings, ...

China announced a wide range of measures on Tuesday targeting U.S. businesses including Google , farm equipment makers and ...

Illumina is down 15.2% since the beginning of the year, and at $111.06 per share, it is trading 28.4% below its 52-week high of $155.15 from November 2024. Investors who bought $1,000 worth of ...

(Reuters) -Shares of genetic testing company Illumina (NASDAQ ... company's revenue from China represents only about 1% of its global sales.